The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs
顯示簡易詮釋資料 統計資料| 欄位 | 內容 | 語言 |
|---|---|---|
dc.citation.epage |
178 | en_US |
dc.citation.spage |
153 | en_US |
dc.citation.volume |
57 | en_US |
dc.contributor.author |
Wang, Yen-Jen | en_US |
dc.contributor.author |
Larsson, Mikael | en_US |
dc.contributor.author |
Huang, Wei-Ting | en_US |
dc.contributor.author |
Chiou, Shih-Hwa | en_US |
dc.contributor.author |
Nicholls, Stephen J. | en_US |
dc.contributor.author |
Chao, Jui-I | en_US |
dc.contributor.author |
Liu, Dean-Mo | en_US |
dc.contributor.department |
材料科學與工程學系 | zh_TW |
dc.contributor.department |
生物科技學系 | zh_TW |
dc.contributor.department |
Department of Materials Science and Engineering | en_US |
dc.contributor.department |
Department of Biological Science and Technology | en_US |
dc.date.accessioned |
2017-04-21T06:55:23Z | |
dc.date.available |
2017-04-21T06:55:23Z | |
dc.date.issued |
2016-06 | en_US |
dc.description.abstract |
This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the ossibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy. (c) 2016 Elsevier Ltd. All rights reserved. | en_US |
dc.identifier.doi |
10.1016/j.progpolymsci.2016.01.002 | en_US |
dc.identifier.issn |
0079-6700 | en_US |
dc.identifier.journal |
PROGRESS IN POLYMER SCIENCE | en_US |
dc.identifier.uri |
http://dx.doi.org/10.1016/j.progpolymsci.2016.01.002 | en_US |
dc.identifier.uri |
https://ir.lib.nycu.edu.tw/handle/11536/133739 | |
dc.identifier.wosnumber |
WOS:000377830500005 | en_US |
dc.language.iso |
en_US | en_US |
dc.subject |
Cardiovascular diseases | en_US |
dc.subject |
Drug delivery | en_US |
dc.subject |
Nanoparticles | en_US |
dc.subject |
Nanostructured | en_US |
dc.subject |
Polymers | en_US |
dc.subject |
Theranostic | en_US |
dc.title |
The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs | en_US |
檔案
本條目沒有附加檔案。
所屬典藏: 期刊論文
引用此條目
Wang, Y.-J., Larsson, M., Huang, W.-T., Chiou, S.-H., Nicholls, S. J., Chao, J.-I., & Liu, D.-M. (2016). The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs. PROGRESS IN POLYMER SCIENCE, 57, 153–178. https://doi.org/10.1016/j.progpolymsci.2016.01.002
引用文字依 APA 第 7 版格式自動產生,使用前請再核對。
分享
永久網址:https://ir.lib.nycu.edu.tw/handle/11536/133739